Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat

Journal of Clinical Investigation

Volumn 100, Issue 12, 1997, Pages 2984-2994

  Kallio, Erkki A ^a,c   Koskinen, Petri K ^a   Aavik, Einari ^a   Vaali, Kirsi ^b   Lemstöm, Karl B ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Transplantation Laboratory   (Finland)

Author keywords

Aminoguanidine; Inducible nitric oxide synthase; L arginine; Lung; Transplantation

Indexed keywords

AMINOGUANIDINE; ARGININE; INTERLEUKIN 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY EPITHELIUM; SMOOTH MUSCLE FIBER; TRACHEA;

EID: 0031438636     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119852     Document Type: Article

References (48)

1. Lemström, K., P. Koskinen, and P. Häyry. 1995. Molecular mechanisms of chronic renal allograft rejection. Kidney. Int. 48:S2-S10.
2. Morris, R.E., X. Huang, C.R. Gregory, M.E. Billingham, R. Rowan, R. Shorthouse, and G.J. Berry. 1995. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivates (Leflunomide and its analogue) for suppression of graft vascular disease and obliterative bronchiolitis. Transplant. Proc. 27:2068-2069.
3. Koskinen, P.K., E.A. Kallio, C.A. Bruggeman, and K.B. Lemström. 1997. Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts. Am. J. Respir. Crit. Care Med. 155:2078-2088.
4. Koskinen, P.K., E.A. Kallio, R. Krebs, and K.B. Lemström. 1997. A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts. Am. J. Respir. Crit. Care Med. 155:303-312.
5. Yousem, S.A., J.B. Berry, P.T. Cagle, D. Chamberlain, A.N. Husain, H.R. Hruban, A. Marchevsky, N.P. Ohori, J. Ritter, S. Stewart, and H.D. Tazelaar. 1996. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: lung rejection study group. J. Heart Lung Transplant. 15:1-15.
6. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-2012.
7. Sessa, W.C. 1994. The nitric oxide synthase family of proteins. J. Vasc. Res. 31:131-143.
8. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB (Fed Am. Soc. Exp. Biol.) J. 6:3051-3064.
9. Moncada, S., and E.A. Higgs. 1995. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB (Fed. Am. Soc. Exp. Biol.) J. 9: 1319-1330.
10. Guo, F.H., H.R. De Raeve, T.W. Rice, D.J. Stuehr, F.B.J.M. Thunnissen, and S.C. Erzurum. 1995. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc. Natl. Acad. Sci. USA. 92:7809-7813.
11. Barnes, P.J. 1995. Nitric oxide and airway disease. Ann. Mad. 27:389-393.
12. Yan, Z.-Q., G.K. Hansson, B.-E. Skoogh, and J.O. Lötvall. 1995. Induetion of nitric oxide synthase in a model of allergic occupational asthma. Allergy (cph). 50:760-764.
13. Tsuji, M., V.B. Dimov, and T. Yoshida. 1995. In vivo expression of monokine and inducible nitric oxide synthase in experimentally induced pulmonary granulomatous inflammation. Am. J. Palhol. 147:1001-1015.
14. Hamid, Q., D.R. Springall, V. Riveros-Moreno, P. Chanez, P. Howarth, A. Redington, J. Bousquet, P. Godard, S. Holgate, and J.M. Polak. 1993. Induction of nitric oxide synthase in asthma. Lancet. 342:1510-1513.
15. Yang, X., N. Chowdhury, B. Cai, J. Brett, C. Marboe, R.R. Sciacca, R.E. Michler, and P.J. Cannon. 1994. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J. Clin. invest. 94:714-721.
16. Langrehr, J.M., N. Murase, P.M. Markus, X. Cai, P. Neuhaus, W. Schraut, R.L. Simmons, and R.A. Hoffman. 1992. Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J. Clin. Invest. 90: 679-683.
17. Misko, T.P., W.M. Moore, T.P. Kasten, G.A. Nickols, J.A. Corbett, R.G. Tilton, M.L. McDaniel, J.R. Williamson, and M.G. Currie. 1993. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:119-125.
18. Worrall, N.K., W.D. Lazenby, T.P. Misko, T.-S. Lin, C.P. Rodi, P.T. Manning, R.G. Tilton, J.R. Williamson, and T.B. Ferguson, Jr. 1995. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J. Exp. Med. 181:63-70.
19. Shiraisi, T., S.R. DeMeester, N.K. Worrall, J.H. Ritter, T.P. Misko, T.B. Ferguson, Jr., J.D. Cooper, and G.A. Patterson. 1995. Inhibition of inducible nitric oxide synthase ameliorates rat lung allograft rejection. J. Thorac. Cardiovasc. Surg. 110:1449-1460.
20. Cooke, J.P., A.H. Singer, P. Tsao, P. Zera, R.A. Rowan, and M.E. Billingham. 1992. Antiatherogenic effect of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90:1168-1172.
21. Lemström, K.B., P.T. Aho, C.A. Bruggeman, and P.J. Häyry. 1994. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-β1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis. Arterioscler. Thromb. 14:2043-2052.
22. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
23. Moshage, H., B. Kok, J.R. Huizenga, and P.L.M. Jansen. 1995. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin. Chem. 41:892-896.
24. Schmidt, H.H.H.W., T.D. Warner, M. Nakane, U. Förstermann, and F. Murad. 1992. Regulation and subcellular location of nitric oxide synthases in RAW264.7 macrophages. Mol. Pharmacol. 41:615-624.
25. Hertz, M.I., J. Jessurun, M.B. King, S.K. Savik, and J.J. Murray. 1993. Reproduction of the obliterative bronchiolitis after heterotopic transplantation of mouse airways. Am. J. Pathol. 142:1945-1951.
26. Reichenspurner, H., X. Huang, V. Soni, R. Shorthouse, G. Berry, and R.E. Morris. 1995. Pathogenesis and treatment of obliterative airway disease after heterotopic tracheal allograft and xenograft transplantation. Surg. Forum. 156:456-458.
27. Uyama, T., J.B. Winter, G. Groen, C.R.H. Wildevuur, Y. Monden, and J. Prop. 1992. Late airway changes caused by chronic rejection in rat lung allografts. Transplantation (Baltimore). 54:809-812.
28. King, M.B., J. Jessurun, S.K. Savik, J.J. Murray, and M.I. Hertz. 1997. Cyclosporine reduces development of obliterative bronchiolitis in a murine heterotopic airway model. Transplantation (Baltimore). 63:528-532.
29. Pinsky, D.J., M.C. Oz, S. Koga, Z. Taha, M.J. Broekman, A.J. Marcus, H. Liao, Y. Naka, J. Brett, P.J. Cannon, et al. 1994. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J. Clin. Invest. 93:2291-2297.
30. Cooke, J.P., and P.S. Tsao. 1993. Cytoprotective effects of nitric oxide. Circulation. 88:2451-2454.
31. Russel, M.E., A.F. Wallace, L.R. Wyner, J.B. Newell, and M.J. Karnovsky. 1995. Upregulation and modulation of inducible nitric oxide synthetase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation. 92:457-464.
32. Akyürek, L.M., B.C. Fellström, Z.-q. Yan, G.K. Hansson, K. Funa, and E. Larsson. 1996. Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic grafts. Am. J. Pathol. 149:1981-1990.
33. Naruse, K., K. Shimizu, M. Marumatso, Y. Toki, Y. Miyazaki, K. Okumura, H. Hashimoto, and T. Ito. 1994. Long-term inhibition of NO synthesis promotes artherosclerosis in the hypercholesterolemic rabbit aorta. Arterioscler. Thromb. 14:746-752.
34. Hou, J.H., H. Kato, R.A. Cohen, A.V. Chobanian, and P. Brecher. 1995. Angitensin II-induced cardiac fibrosis in rhe rat increased by chronic inhibition of nitric oxide synthase. J. Clin. Invest. 96:2469-2477.
35. McNamara, D.B., B. Bedi, H. Aurora, L. Tena, L.J. Ignarro, P.J. Kadowitz, and D.L. Akers. 1993. L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem. Biophys. Res. Commun. 193:291-296.
36. Gregory, C.R., J.P. Cooke, J.D. Patz, E.R. Berryman, R. Shorthouse, and R.E. Morris. 1996. Enhanced nitric oxide production induced by the administration of L-arginine does not inhibit arterial neointimal formation after overwhelming alloimmune injury. J. Heart. Lung Transplant. 15:58-66.
37. Langrehr, J.M., D.A. White, R.A. Hoffman, and R.L. Simmons. 1993. Macrophages produce nitric oxide at allograft sites. Ann. Surg. 218:159-166.
38. Kourembanas, S., L.P. McQuillan, G.K. Leung, and D.V. Faller 1993. Nitric oxide regulates expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest. 92:99-104.
39. Hertz, M.I., C.A. Henke, R.E. Nakhleh, K.R. Harmon, W.A. Marinelli, J.M.K. Fox, S.H. Kubo, S.J. Shumway, R.M. Bolman, III, and P.B. Bitterman. 1992. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet derived growth factor. Proc. Natl. Acad. Sci. USA. 89:10385-10389.
40. Al-Dossari, G.A., J. Jessurun, R. Morton Bolman, III, R.K. Vibhu, M.B. King, J.J. Murray, and M.I. Hertz. 1995. Pathogenesis of obliterative bronchiolitis: Possible role of platelet derived growth factor and basic fibroblast growth factor. Transplantation (Baltimore). 59:143-145.
41. Kariya, K.-i., Y. Kawahara, S.-i. Araki, H. Fukuzaki, and Y. Takai. 1989. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit smooth muscle cells. Atherosclerosis. 80:143-147.
42. Garg, U.C., and A. Hassid. 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1774-1777.
43. Radomski, M.W., R.M.J. Palmer, and S. Moncada. 1990. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA. 87:5193-5197.
44. Murohara, T., S.J. Parkinson, S.A. Waldman, and A.M. Lefer. 1995. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Arterioscler. Thromb. Vasc. Biol. 15:2068-2075.
45. Kubes, P., M. Suzuki, and D.N. Granger. 1991. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA. 88:4651-4655.
46. Sayegh, M.H., E. Akalin, W.W. Hancock, M.E. Russel, C.B. Carpenter, P.S. Linsley, and L.A. Turka. 1995. CD28-B7 Blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181:1869-1874.
47. Taylor-Robinson, A.W., F.Y. Liew, A. Severn, D. Xu, S.J. McSorley, P. Garside, J. Padron, and R.S. Phillips. 1994. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24:980-984.
48. Wei, X.-q., I.G. Charles, A. Smith, J. Ure, G.-j. Feng, F.-p. Huang, D. Xu, W. Muller, S. Moncada, and F.Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:408-411.